Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 32, Issue 11-12, Pages 1315-1322Publisher
WILEY-BLACKWELL PUBLISHING, INC
DOI: 10.1111/j.1365-2036.2010.04480.x
Keywords
-
Funding
- Institut National de la Sante et de la Recherche Medicale (France)
- University of Nice
- Programme Hospitalier de Recherche Clinique (CHU of Nice)
- AFEF/Schering-Plough
- AFEF/ROCHE
Ask authors/readers for more resources
P>Background Non-invasive approaches are useful to differentiate simple steatosis from non-alcoholic steatohepatitis (NASH) in obese and morbidly obese patients. Aim To develop a new scoring system to diagnose definitive NASH. Methods Preoperative clinical and biological data including serum caspase 3-generated cytokeratin-18 fragments (CK18) and surgical liver biopsies were obtained from 464 morbidly obese patients who had undergone bariatric surgery. The cohort was divided into two groups: training group (n = 310) and validation group (n = 154). Definitive NASH was defined according to Kleiner's classification with a Non-alcoholic fatty liver disease Activity Score (NAS) >= 5. Results Alanine aminotransferase (ALT), CK18 fragments and the presence of metabolic syndrome were independent predictors for discriminating patients with NAS >= 5 in the training group. These three parameters were used to carry out a scoring system for the prediction of NAS >= 5. Whereas serum CK18 fragment alone had an area under the receiver operating characteristic (AUROC) curve = 0.74, AUROC curves of the scoring system were 0.88 and 0.83 in the training group and the validation group, respectively. Conclusion A simple and non-invasive composite model (the Nice Model) including metabolic syndrome, ALT and CK18 fragments is able to predict accurately a non-alcoholic fatty liver disease activity score >= 5 in morbidly obese subjects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available